Cargando…
Metal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment
Helicobacter pylori (H. pylori) is an infectious pathogen and the leading cause of gastrointestinal diseases, including gastric adenocarcinoma. Currently, bismuth quadruple therapy is the recommended first-line treatment, and it is reported to be highly effective, with >90% eradication rates on a...
Autores principales: | Yin, Xiaojing, Lai, Yongkang, Du, Yiqi, Zhang, Tinglin, Gao, Jie, Li, Zhaoshen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182771/ https://www.ncbi.nlm.nih.gov/pubmed/37192898 http://dx.doi.org/10.2147/IJN.S405052 |
Ejemplares similares
-
Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives
por: Lai, Yongkang, et al.
Publicado: (2022) -
Survival Outcome of Gastric Signet Ring Cell Carcinoma Based on the Optimal Number of Examined Lymph Nodes: A Nomogram- and Machine-Learning-Based Approach
por: Lai, Yongkang, et al.
Publicado: (2023) -
Helicobacter pylori Treatment Strategies in Singapore
por: Ang, Tiing Leong, et al.
Publicado: (2021) -
Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022) -
Recent progress in Helicobacter pylori treatment
por: Hu, Yi, et al.
Publicado: (2020)